Janice Troha, Nivalis Therapeutics, Inc.'s Exec Vice President / COO, recently acquired 10,000 shares of the company. The buys took place at $2.34 per share, on May 05, 2017. Troha now owns 10,000 shares of the company. Troha operates out of Boulder, CO. Some additional info was provided as follows:
The price recorded in Column 4 represents the actual price for the full block purchase.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Nivalis Therapeutics, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Securities to be offered to employees in employee benefit plans - June 21, 2018
Departure of Directors or Certain - June 14, 2018
Nivalis Therapeutics, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - June 11, 2018
Entry into a Material Definitive - June 11, 2018